PRGO
39
3
BF.B
33
2
F
58
11
VRSN
53
-4
DNB
82
4
DE
63
3
CFG
70
6
XRAY
28
2
EXC
53
-3
PM
62
-2
PLD
56
8
WBA
48
4
LH
43
-2
UPS
60
9
DOW
44
10
LEG
36
4
CA
38
6
GE
67
2
FDX
43
3
NAVI
52
5
PRGO
39
3
BF.B
33
2
F
58
11
VRSN
53
-4
DNB
82
4
DE
63
3
CFG
70
6
XRAY
28
2
EXC
53
-3
PM
62
-2
PLD
56
8
WBA
48
4
LH
43
-2
UPS
60
9
DOW
44
10
LEG
36
4
CA
38
6
GE
67
2
FDX
43
3
NAVI
52
5
Financhill
Back

Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

INO
Inovio Pharmaceuticals

Last Price:
4.07
Seasonality Move:
18.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Inovio Pharmaceuticals Price Quote

$4.07

Inovio Pharmaceuticals Key Stats

Sell
20
Inovio Pharmaceuticals (INO) is a Sell
Day range:
$4.04 - $4.22
52-week range:
$3.85 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.44%
Volume:
292.7K
Avg. volume:
333.3K
1-year change:
-16.81%
Market cap:
$106.2M
Revenue:
$832K
EPS:
$-4.47

How Much Does Inovio Pharmaceuticals Make?

Data Unavailable

Is Inovio Pharmaceuticals Growing As A Company?

Data Unavailable

Inovio Pharmaceuticals Stock Price Performance

What Is Inovio Pharmaceuticals 52-Week High & Low?

Inovio Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inovio Pharmaceuticals?

Is Inovio Pharmaceuticals Cash Flow Positive?

  • What Is INO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$110.7M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $24.2M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $89.4M

Inovio Pharmaceuticals Return On Invested Capital

Data Unavailable

Inovio Pharmaceuticals Earnings Date & Stock Price

Inovio Pharmaceuticals Competitors

Inovio Pharmaceuticals Dividend Yield

Inovio Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.38%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 10.67
Upside from Last Price: 162.08%

Major Shareholders

  • How many INO shares are owned by institutional investors?
    12.9M INO shares are owned by institutional investors
  • How many INO shares are owned by insiders?
    4.6M INO shares are owned by insiders